HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications

HTL Biotechnology France New York

– 07 61 45 26 85
Olivier Clement – [e-mail] – 07 64 47 24 07
Agence APCO : Nina Pereira – [e-mail] – 06 80 20 23 02

Logo - https://mma.prnewswire.com/media/2404503/HTL_Biotechnology_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/htl-biotechnology-market-leader-in-biopolymers-acquires-the-modern-meadows-human-recombinant-collagen-platform-for-beauty-and-biomedical-applications-302135899.html